HCMTDirexion HCM Tactical Enhanced U.S. Equity Strategy ETF
Seeks capital appreciation.
By Direxion Funds · Launched 2023
Annual Cost
1.18%
#5,472 of 5,854 · expensive
Fund Size
$622M
#1,439 of 5,854 · large
Return (1Y)Goal
+14.4%
Track Record
3 years
#2,969 of 5,854 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$11,525+15.3%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 73.2% of fundconcentrated
DREYFUS GOVERNMENT CASH MANAGE
41.5%
GOLDMAN SACHS LIQ ES FD A
12.9%
DREYFUS
5.0%
NVIDIA Corp.
3.1%
Apple Inc.
2.6%
Microsoft Corp.
2.0%
N/A
1.8%
Amazon.com, Inc.
1.7%
Alphabet Inc.
1.4%
Broadcom Inc
1.3%
Asset allocation
Stocks
83.3%
Cash
8.8%
Other
7.9%
By sector
Technology
38.5%
Financial Services
11.6%
Communication
9.9%
Consumer Cyclical
9.5%
Healthcare
8.9%
Industrials
8.4%
Consumer Defensive
4.5%
Energy
3.0%
Other
5.7%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
28.4%High
Year-on-year price swings
Max drawdown
-36.3%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.49Below average
Sortino (3Y)
0.67Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks capital appreciation.
- Strategy
- Actively managed fund aiming for enhanced returns correlated to U.S. equity markets. Invests in U.S. equity securities and cash equivalents, utilizing a proprietary quantitative model to adjust allocations based on market trends. May leverage up to 200% of net assets across various sectors, including health care.
- Inception date
- June 21, 2023
- Fund family
- Direxion Funds
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at HCMT. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-03